|1.||Manzi, Susan: 2 articles (01/2014 - 12/2008)|
|2.||Ahearn, Joseph M: 2 articles (08/2009 - 12/2008)|
|3.||Putterman, Chaim: 1 article (01/2014)|
|4.||Askanase, Anca: 1 article (01/2014)|
|5.||Dervieux, Thierry: 1 article (01/2014)|
|6.||Kalunian, Kenneth: 1 article (01/2014)|
|7.||Furie, Richard: 1 article (01/2014)|
|8.||Ibarra, Claudia: 1 article (01/2014)|
|9.||Barken, Derren: 1 article (01/2014)|
|10.||Ahearn, Joseph: 1 article (01/2014)|
|1.||Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/01/2008 - "Platelets bearing complement C4d were recently reported to be 99% specific for a diagnosis of systemic lupus erythematosus (SLE) and associated with neuropsychiatric lupus. "
01/01/2014 - "To compare the performance characteristics of cell-bound complement (C4d) activation products (CBCAPS) on erythrocyte (EC4d) and B cells (BC4d) with antibodies to double-stranded DNA (anti-dsDNA) and complement C3 and C4 in systemic lupus erythematosus (SLE). "
|4.||Disease Susceptibility (Diathesis)
08/01/2009 - "These include polymorphisms and copy-number variations of complement C4 and Fcgamma receptor genes (disease susceptibility), cell-bound complement C4d (diagnosis and/or disease activity), CD27(high) plasma cells (disease activity), 'interferon signature' (disease activity) and anti-C1q and anti-NMDA (disease activity and organ involvement). "
|4.||Immunoglobulin M (IgM)
|5.||DNA (Deoxyribonucleic Acid)
|6.||Complement C4 (Complement Component 4)
|7.||Complement C3 (C3 Complement)
|1.||Homologous Transplantation (Allograft)